Navigation Links
Acute coronary events decreased after public smoking ban in Italy
Date:2/11/2008

es and from four fixed monitors in residential areas together with temperature readings.

The indoor concentration of fine particles decreased significantly from a mean level of 119 g/m3 before the ban to 43 g/m3 one year after the ban.

During the period of the study there were changes in smoking habits such as:

  • Frequency of smoking decreased from 34.9 percent to 30.5 percent in men and from 20.6 percent to 20.4 percent in women.
  • Cigarette sales decreased 5.5 percent.

While the ban resulted in a significant reduction in acute coronary events in the two younger age groups, the older group (aged 75-84 years) showed no reduction.

When the researchers adjusted for time trends and all-cause hospitalization, the results remained statistically significant in the youngest group and in the 6574 age group. This effect was only slightly reduced when the researchers compared the post-smoking ban data of 2005 to that from 2004.

The older age group spends more time at home than in the workplace or public businesses, said Giulia Cesaroni, M.Sc., senior researcher at the Department of Epidemiology, Rome, Italy. The smoking ban has a greater effect on those of working age and those who spend a lot of their time in public places.

Young people living in low socioeconomic areas seemed to have the greatest reduction in acute coronary events after the smoking ban, researchers reported. Those living in lower socioeconomic areas have worse health conditions with more risk factors for heart attack such as obesity, hypertension, diabetes and a higher rate of active smoking.

This implies that a disadvantaged person has a higher probability of being surrounded by smokers at work and in public places unless a smoking ban is in place, Cesaroni said.

The researchers said the health benefits seen in this study probably result from a significant reduction in exposure to passive smoking. In addition, a s
'/>"/>

Contact: Karen Astle
karen.astle@heart.org
214-706-1392
American Heart Association
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Diabetes appears to increase risk of death for patients with acute coronary syndromes
2. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
3. Study shows insurance status, not race, linked to complications in patients with acute appendicitis
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. Acute lung injury patients one-third less likely to die in closed model ICUs
6. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
7. Short-term hemofiltration is cost-effective for severe acute pancreatitis
8. Baicalin might be a promising therapeutic tool for severe acute pancreatitis
9. Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
10. Renal Solutions, Inc. Announces FDA 510(k) Clearance of New Design of the Allient(R) Sorbent Hemodialysis System for Chronic and Acute Hemodialysis
11. Acute pancreatitis and cholangitis: a complication caused by a migrated gastrostomy tube
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Foot and Ankle ... new associate podiatrist, creating the largest medical practice in the Mid-Atlantic region – and ... FASMA operates 21 locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Did you know ... Orange County looking for exceptional and affordable home care options which A-1 Home Care ... just a few of the credentials A-1 Home Care Agency is known ...
(Date:8/2/2015)... (PRWEB) , ... August 03, 2015 , ... A new ... of some childhood cancers. The study is led by Kenneth G. Lucas, M.D. ... University of Louisville in collaboration with colleagues at Kosair Children’s Hospital and ...
(Date:8/2/2015)... ... , ... Molecular biologists in New South Wales say a protein linked to ... posted an article on the new research. Click here to read it now. ... in tissue samples from 42 patients with peritoneal mesothelioma and found a direct correlation ...
(Date:8/1/2015)... ... August 01, 2015 , ... ... are in “a trending profession” that comprises a growing percentage of U.S. physicians, ... most. , That was one part of the message delivered by John W. ...
Breaking Medicine News(10 mins):Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5
... de Toulouse-Lautrec suffered, is a genetic disease characterized by ... into how joints are destroyed by arthritis. It is ... K which hampers osteoclasts (the cells that break down ... bone resorption and dense, brittle bones. , Cathepsin ...
... Patients Received Assistance with Drug Co-Pays, HOUSTON, Nov. ... a national oral oncology specialty pharmacy, has,exceeded the $10 ... co-pays since the launch of Care Advantage in August ... Advantage to be able to,increase patient access to oral ...
... 4 Mylan Inc. (NYSE: MYL ),today ... approval from the U.S. Food and Drug Administration ... Levetiracetam Tablets, 250 mg,500 mg and 750 mg. ... Keppra(R)., Robert J. Coury, Mylan,s Vice Chairman ...
... blood pressure experienced during pregnancy could be a woman,s ... heart disease the number one killer of Canadian ... Gynecology, Graeme Smith. , Called pre-eclampsia, this type ... of all pregnancies. , But because most practicing ...
... , , TUESDAY, Nov. 4 (HealthDay News) -- Children who live ... undernourished, a new study finds. , The same is true ... impact the most, said study author Dr. Michael Weitzman, chairman ... "We know that there are long-term consequences of food insecurity ...
... Secretary and other members of bipartisan,group of Capitol ... energy, transportation, trade, labor and employment,and tax policy, ... and grueling,Presidential campaign, one thing is certain: change ... with or regulated by the federal government,will face ...
Cached Medicine News:Health News:Genetic disorder sheds light on enzyme's role in bone metabolism 2Health News:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance 2Health News:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance 3Health News:Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately 2Health News:Pregnancy disorder signals need to screen for heart disease 2Health News:Smokers' Homes More Likely to House Hungry Kids 2Health News:Smokers' Homes More Likely to House Hungry Kids 3Health News:Venable's 'Election Watch Group' Assesses Presidential Election's Impact on Multiple Industries 2Health News:Venable's 'Election Watch Group' Assesses Presidential Election's Impact on Multiple Industries 3
(Date:8/3/2015)... 2015  Array BioPharma Inc. (NASDAQ: ARRY ... and full year of its fiscal year ended ... Executive Officer of Array, noted, "Binimetinib and encorafenib, two ... track for regulatory submissions in 2016. Additional data ... BRAF-mutant colorectal cancer further validate the value of ...
(Date:8/3/2015)... Aug. 3, 2015  Charleston Laboratories, Inc., an ... second clinical development program with a Phase 1 ... CL-H1T contains fast-dissolving promethazine and sumatriptan.  ... a treatment for migraine headache pain and migraine-induced ... patients with migraine headaches also suffer from nausea ...
(Date:8/3/2015)... FLORHAM PARK, N.J. , Aug. 3, ... met its primary and secondary endpoints in a phase ... constipation (OIC) in adult patients with chronic non-cancer pain. ... antagonist (PAMORA). This is the third Phase III trial ... endpoints. Study results showed that a 0.2 ...
Breaking Medicine Technology:Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4
... Biosafety , , , ... June 29 Remember chemistry sets, ham radio, amateur astronomy, and early ... around the world belong to the Do-It-Yourself Biology (DIYbio) community, working on everything ... treatments for diseases. , , , ...
... Ireland , June 28 Warner Chilcott plc ... IV Certification Notice from Par Pharmaceutical, Inc. ("Par").  The Paragraph IV Certification ... Application (ANDA) by Par for a generic version of the Company,s ASACOL ... , , ...
Cached Medicine Technology:Responsible Science for Do-It-Yourself Biologists 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: